UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
Rhea-AI Summary
Clover Health (Nasdaq: CLOV) is live on Kno2 and participating in CMS-aligned interoperability initiatives, enabling real-time, patient-directed responses for clinical and claims data using FHIR (USCDI v3) standards.
Participation is powered by Counterpart Health infrastructure and Kno2 routing; live demonstrations will run March 10–12, 2026 at HIMSS 2026.
Positive
- Live production interoperability on Kno2 supporting real-time patient-directed claims responses
- Uses standardized FHIR (USCDI v3) formats for structured clinical and claims data exchange
- Counterpart Health infrastructure enables potential extension of capabilities to other health plans
- Planned live demonstrations March 10–12, 2026 at HIMSS 2026 Aligned Networks Showcase
Negative
- None.
News Market Reaction – CLOV
In the Mar 10 session, CLOV declined 0.50%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 04 | Interoperability milestone | Positive | +8.0% | First payer live on CMS Aligned Network with real-time FHIR data exchange. |
| Feb 26 | Earnings and guidance | Positive | -2.8% | Strong 2025 growth and 2026 profitability guidance followed by a price decline. |
| Feb 17 | Conference appearance | Neutral | +2.5% | Announcement of participation in Leerink 2026 Global Healthcare Conference. |
| Jan 29 | Earnings date notice | Neutral | -1.3% | Scheduling disclosure for Q4 and full-year 2025 results webcast. |
| Jan 14 | Membership update | Positive | +10.6% | 53% MA membership growth to ~153,000 and expectation of 2026 GAAP profitability. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent operational and growth updates, particularly on membership and interoperability, often coincided with positive price reactions, while earnings/guidance news saw at least one negative reaction despite growth metrics.
Over the last few months, Clover Health reported strong Medicare Advantage growth and outlined a path toward potential GAAP profitability, with revenues of $1.9B in 2025 and guidance for higher revenue and membership in 2026. News on interoperability and CMS-aligned networks, including being first live on a CMS Aligned Network, drew positive reactions such as an 8% move on Mar 4. Earlier, an AEP update showing 53% MA membership growth produced a 10.63% gain. Conference participation and earnings-date notices had more muted effects.
Key Terms
interoperability technical
fhir technical
uscdi v3 technical
tefca regulatory
medicare advantage medical
value-based care medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Clover Health's early adoption of real-time patient access to claims data on Kno2 is made possible by underlying infrastructure powered by Counterpart Health
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of Clover Health's participation in federal interoperability initiatives.
WILMINGTON, Del., March 10, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, and Kno2, healthcare’s leading communication network, today announced a collaboration enabling Clover Health to be live on a network that is participating in interoperability efforts publicly announced by the Centers for Medicare & Medicaid Services (CMS) to drive interoperability goals. Clover is demonstrating that nationwide, interoperable data exchange is not aspirational, it is achievable today.
Through this collaboration, Clover Health now responds in real time to patient-directed requests for clinical and claims data using standardized FHIR (USCDI v3) formats. This activity is consistent with publicly described CMS Health Tech Ecosystem, including the CMS-aligned network concepts and TEFCA’s IAS implementation, enabling patients to securely authenticate and request their health information from any participating payer through a connected network.
As patients move across care settings, seamless data exchange becomes critical. A Medicare patient with multiple chronic conditions may transition between primary care, specialty care, hospital, and home-based services. With standards-based interoperability, care teams remain aligned, enabling proactive, coordinated care within a value-based model.
Clover Health’s participation is powered by Counterpart Health, its technology and services business that enables physicians, payers, and risk-based entities to achieve outsized success in value-based care by leveraging a wide range of clean clinical data at scale. Kno2 securely routes patient-directed requests across the network and Counterpart Health enables the standardized exchange of data. Clover Health then responds as the payer with structured clinical and claims information.
Clover Health’s early participation reflects its support for broader national interoperability efforts and demonstrates how interoperable, patient-directed data exchange can operationalize today. Because the underlying infrastructure is powered by Counterpart Health, similar technical capabilities may be extended to other health plans seeking to participate in interoperability networks.
“Counterpart Assistant was built from the ground up as a bi-directional interoperable platform, already connecting hundreds of data sources. These are not bolt-on capabilities or compliance projects. They are foundational components of how the system operates in production,” said Kevin Holub, Chief Product Officer at Counterpart Health. “When that infrastructure already exists, participating in aligned networks becomes a fast add on benefit, not a build.”
"When our members have secure, real-time access to their clinical and claims information, it enables both transparency and control, including easier sharing with caregivers and providers, and ultimately a deeper understanding of their own health journey," said Jamie Reynoso, CEO of Medicare Advantage at Clover Health. “Because of Clover Assistant and the infrastructure we already have in place through Counterpart Health, we are well positioned to meet member needs like this today."
"Clover Health's willingness to enable real-time patient access to claims data, sets the standard for payers everywhere. We're proud to enable this milestone and look forward to expanding into broader interoperability initiatives as CMS and TEFCA have put forth." said Therasa Bell, President & Founder, Kno2.
Clover Health, Kno2, and Counterpart Health will conduct live demonstrations of an end-to-end response to a patient authenticated claims data request March 10 - 12, 2026 throughout HIMSS 2026 in the Aligned Networks Showcase at the Kno2 booth #12720. The demonstration will show a patient request flowing through the network via Kno2, reaching Counterpart Health’s responding gateway, and securely returning structured clinical and claims data from Clover Health’s infrastructure.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale.
Visit: www.cloverhealth.com
About Counterpart Health:
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on Diabetes, Chronic Kidney Disease, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease management, as well as Clinical Quality and Underserved Patient Populations.
About Kno2:
Kno2 is leading the future of healthcare communication by providing the nation’s largest comprehensive communication network including as a federally designated Qualified Health Information Network (QHIN) and CMS Aligned network. Kno2 enables secure, effortless exchange of patient information across providers, payers, patients, and technology vendors, processing billions of transactions annually.
Media Contacts:
Clover Health: press@cloverhealth.com
